肝病对鼻出血住院患者结局的影响
基于2002至2013年全国住院患者样本,共39,879例以鼻出血为主要诊断的住院病例,其中3.6%合并肝病。P=0.001),且侵袭性治疗率较低。
要点
- 肝病患者侵袭性治疗(结扎或栓塞)率较低(6.6%-9.0%;P<0.002)。
核心结论
- 在鼻出血住院患者中,肝病导致更高的发病率和死亡率。
研究设计与样本
- 查询2002至2013年全国住院患者样本中主要诊断为鼻出血的病例,识别符合AHRQ肝病定义的病例并与非肝病队列比较。
主要发现
- 共纳入39,879例,3.6%合并肝病。
- 肝病组年龄55.7岁 vs 非肝病组67.5岁(P<0.001),住院时间3.9天 vs 3.2天(P<0.001),住院费用$26,141 vs $18,200(P<0.001)。
- 肝病患者酒精滥用、凝血病、慢性失血性贫血和肾衰竭发生率更高。
- 肝病患者脓毒症、泌尿/肾脏并发症、呼吸衰竭和感染性肺炎发生率更高。
- 肝病与侵袭性治疗(结扎或栓塞)率降低相关(6.6%-9.0%;P<0.002),并与前/后鼻腔填塞率降低相关。
关键数值与推荐
- 证据等级:2C。
临床怎么用
- 临床医生应意识到肝病对鼻出血住院患者的特定风险。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Liver disease (LD) often results in coagulation abnormalities that may predispose to more severe epistaxis. The purpose of this analysis was to examine characteristics of patients hospitalized for epistaxis with LD and explore the impact of LD on patient outcomes. METHODS: The 2002 to 2013 National Inpatient Sample was queried for cases with a primary diagnosis of epistaxis. Cases with additional codes meeting the Agency for Healthcare Research and Quality's definition of LD were identified and compared to the non-LD cohort. RESULTS: Out of 39,879 cases meeting inclusion criteria, 3.6% had LD. LD was associated with younger age (55.7 years vs. 67.5 years; P < 0.001), longer hospital stay (3.9 days vs. 3.2 days; P < 0.001), and greater hospital charges ($26,141 vs. $18,200; P < 0.001) compared to the non-LD cohort. LD patients had higher rates of alcohol abuse, coagulopathy, chronic blood loss anemia, and renal failure. LD patients also had higher rates of sepsis, urinary/renal complications, respiratory failure, and infectious pneumonia. LD was associated with decreased rates of aggressive management (defined as ligation or embolization) (6.6%-9.0%; P < 0.002) and anterior or posterior nasal packing. In our multivariate logistic regression model correcting for age, gender, race, and significant comorbidities, LD was associated with 1.520 (1.336-1.729; P < 0.001) greater odds of transfusion and 2.264 (1.372-3.736; P = 0.001) greater odds of in-hospital mortality. CONCLUSION: Among patients hospitalized for epistaxis, LD resulted in greater morbidity and mortality. Clinicians should be aware of the particular risk that LD bears on the hospitalized epistaxis patient. LEVEL OF EVIDENCE: 2C. Laryngoscope, 127:2691-2697, 2017.
引用
- Mohamed OM, Govindan A, Filimonov A, et al. Impact of liver disease on outcomes of patients hospitalized for epistaxis. Laryngoscope. 2017. PMID: 28555879. doi:10.1002/lary.26624
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。